| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the evidence gap for HIV prevention in pregnancy
|
Donnell, Deborah
|
|
|
|
3 |
p. e144-e145
|
artikel
|
| 2 |
Adherence among post-partum women living with HIV
|
Scott, Rachel K
|
|
|
|
3 |
p. e152-e154
|
artikel
|
| 3 |
Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data
|
Rosenberg, Nora E
|
|
|
|
3 |
p. e175-e185
|
artikel
|
| 4 |
Advancing knowledge in perinatal HIV treatment
|
Waitt, Catriona
|
|
|
|
3 |
p. e124-e125
|
artikel
|
| 5 |
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study
|
Chamie, Gabriel
|
|
2016
|
|
3 |
p. e111-e119
nvt p.
|
artikel
|
| 6 |
AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study
|
Lima, Viviane D
|
|
2015
|
|
3 |
p. e92-e97
nvt p.
|
artikel
|
| 7 |
Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection
|
O'Donnell, Max R
|
|
2019
|
|
3 |
p. e201-e204
|
artikel
|
| 8 |
Associations between punitive policies and legal barriers to consensual same-sex sexual acts and HIV among gay men and other men who have sex with men in sub-Saharan Africa: a multicountry, respondent-driven sampling survey
|
Lyons, Carrie E
|
|
|
|
3 |
p. e186-e194
|
artikel
|
| 9 |
Breast cancer survival in women living with HIV
|
Simonds, Hannah M
|
|
|
|
3 |
p. e141-e142
|
artikel
|
| 10 |
Call for justice-informed HIV cure trials with ATIs
|
Dubé, Karine
|
|
|
|
3 |
p. e137-e139
|
artikel
|
| 11 |
CD4/CD8 ratio and lung cancer risk
|
Clifford, Gary M
|
|
2017
|
|
3 |
p. e103-
1 p.
|
artikel
|
| 12 |
CD4/CD8 ratio and lung cancer risk – Authors' reply
|
Sigel, Keith
|
|
2017
|
|
3 |
p. e103-e104
nvt p.
|
artikel
|
| 13 |
CD4/CD8 ratio: an emerging biomarker for HIV
|
Serrano-Villar, Sergio
|
|
2015
|
|
3 |
p. e76-e77
nvt p.
|
artikel
|
| 14 |
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
|
Mussini, Cristina
|
|
2015
|
|
3 |
p. e98-e106
nvt p.
|
artikel
|
| 15 |
Centring the health of women across the HIV research continuum
|
Barr, Elizabeth
|
|
|
|
3 |
p. e186-e194
|
artikel
|
| 16 |
Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies
|
Serrano-Villar, Sergio
|
|
|
|
3 |
p. e158
|
artikel
|
| 17 |
Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies – Authors' reply
|
Kahl, Lesley P
|
|
|
|
3 |
p. e158-e159
|
artikel
|
| 18 |
Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study
|
Frank, Simone C
|
|
2019
|
|
3 |
p. e182-e190
|
artikel
|
| 19 |
Comparison of index-linked HIV testing for children and adolescents in health facility and community settings in Zimbabwe: findings from the interventional B-GAP study
|
Dziva Chikwari, Chido
|
|
|
|
3 |
p. e138-e148
|
artikel
|
| 20 |
Correction to Lancet HIV 2017; 4: e122–33.
|
|
|
2017
|
|
3 |
p. e102-
1 p.
|
artikel
|
| 21 |
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
|
Phillips, Andrew N
|
|
2018
|
|
3 |
p. e146-e154
|
artikel
|
| 22 |
Criminal law, sex work, HIV: need for multi-level research
|
Boily, Marie-Claude
|
|
2017
|
|
3 |
p. e98-e99
nvt p.
|
artikel
|
| 23 |
Disparities in approaches to ART access in Europe
|
Tribaudeau, Laure
|
|
|
|
3 |
p. e140
|
artikel
|
| 24 |
Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study
|
Chasimpha, Steady
|
|
|
|
3 |
p. e160-e171
|
artikel
|
| 25 |
Disproportionate disability in people with HIV
|
Rajasuriar, Reena
|
|
|
|
3 |
p. e145-e146
|
artikel
|
| 26 |
Drug consumption room comes to Glasgow
|
Holt, Ed
|
|
|
|
3 |
p. e143-e144
|
artikel
|
| 27 |
Ebola and HIV: managing febrile times
|
Lewin, Sharon R
|
|
2014
|
|
3 |
p. e101-e102
nvt p.
|
artikel
|
| 28 |
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial
|
O'Connor, Jemma
|
|
2017
|
|
3 |
p. e105-e112
nvt p.
|
artikel
|
| 29 |
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial
|
Haberer, Jessica E
|
|
|
|
3 |
p. e130-e137
|
artikel
|
| 30 |
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial
|
Achenbach, Chad J
|
|
2015
|
|
3 |
p. e82-e91
nvt p.
|
artikel
|
| 31 |
Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study
|
Shah, Maunank
|
|
2016
|
|
3 |
p. e140-e146
nvt p.
|
artikel
|
| 32 |
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
|
Mercié, Patrick
|
|
2018
|
|
3 |
p. e126-e135
|
artikel
|
| 33 |
Ending HIV in the UK
|
Kirby, Tony
|
|
|
|
3 |
p. e148-e149
|
artikel
|
| 34 |
End of AIDS on the horizon, but innovation needed to end HIV
|
Vella, Stefano
|
|
2015
|
|
3 |
p. e74-e75
nvt p.
|
artikel
|
| 35 |
Engaging young women in Africa for PrEP use and adherence
|
Maharaj, Bhavna
|
|
|
|
3 |
p. e122-e123
|
artikel
|
| 36 |
Equity in access to long-acting injectables in the USA
|
Hojilla, J Carlo
|
|
|
|
3 |
p. e145-e147
|
artikel
|
| 37 |
Estimating HIV incidence in sub-Saharan Africa
|
Nsanzimana, Sabin
|
|
|
|
3 |
p. e146-e148
|
artikel
|
| 38 |
Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study
|
Geng, Elvin H
|
|
2015
|
|
3 |
p. e107-e116
nvt p.
|
artikel
|
| 39 |
Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial
|
Thirumurthy, Harsha
|
|
2019
|
|
3 |
p. e155-e163
|
artikel
|
| 40 |
First-line HIV therapy shall not fail
|
Boucher, Charles
|
|
2016
|
|
3 |
p. e108-e109
nvt p.
|
artikel
|
| 41 |
Gag rule at odds with progress in HIV/AIDS
|
The Lancet HIV,
|
|
2017
|
|
3 |
p. e93-
1 p.
|
artikel
|
| 42 |
Genetic clusters and transmission in transgender women
|
Gräf, Tiago
|
|
2019
|
|
3 |
p. e143-e144
|
artikel
|
| 43 |
GHESKIO: adapting to challenges in Haiti since the early 1980s
|
Daniels, Joe Parkin
|
|
2019
|
|
3 |
p. e153
|
artikel
|
| 44 |
Global Gag Rule must be repealed for good
|
The Lancet HIV,
|
|
|
|
3 |
p. e121
|
artikel
|
| 45 |
Going the last mile in the USA
|
Nelson, Roxanne
|
|
|
|
3 |
p. e153
|
artikel
|
| 46 |
Haiti's complex history with HIV, and recent successes
|
Daniels, Joe Parkin
|
|
2019
|
|
3 |
p. e151-e152
|
artikel
|
| 47 |
Handing over the camera: “artivists” in ten cities tell their stories
|
Lucas, Catherine
|
|
|
|
3 |
p. e162-e163
|
artikel
|
| 48 |
Highlights of HIVR4P // Virtual
|
Harris, Philippa
|
|
|
|
3 |
p. 129
|
artikel
|
| 49 |
HIV and people who inject drugs: inequality until death
|
Seguin-Devaux, Carole
|
|
|
|
3 |
p. e136-e137
|
artikel
|
| 50 |
HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling
|
Harris, Tiffany G
|
|
|
|
3 |
p. e182-e201
|
artikel
|
| 51 |
HIV continuity of care after Cyclone Idai in Mozambique
|
Pozniak, Anton
|
|
|
|
3 |
p. e159-e160
|
artikel
|
| 52 |
HIV self-testing, PrEP, and drug resistance: some insights
|
Ochieng, Walter
|
|
|
|
3 |
p. e134-e136
|
artikel
|
| 53 |
HIV targets unattainable with gender-based inequalities
|
Adepoju, Paul
|
|
|
|
3 |
p. e127-e128
|
artikel
|
| 54 |
HIV transmission and source–sink dynamics in sub-Saharan Africa
|
Okano, Justin T
|
|
|
|
3 |
p. e209-e214
|
artikel
|
| 55 |
HIV transmission networks among transgender women in Los Angeles County, CA, USA: a phylogenetic analysis of surveillance data
|
Ragonnet-Cronin, Manon
|
|
2019
|
|
3 |
p. e164-e172
|
artikel
|
| 56 |
How can we end paediatric AIDS?
|
Celletti, Francesca
|
|
2015
|
|
3 |
p. e80-e81
nvt p.
|
artikel
|
| 57 |
Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling study
|
Cox, Sarah N
|
|
|
|
3 |
p. e167-e175
|
artikel
|
| 58 |
Improving outcomes after hospitalisation in people with HIV
|
Laher, Abdullah E
|
|
|
|
3 |
p. e140-e141
|
artikel
|
| 59 |
Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study
|
Howard, Jaime F Borjas
|
|
2019
|
|
3 |
p. e173-e181
|
artikel
|
| 60 |
Increased risk of mental illness in people with HIV
|
Lampe, Fiona C
|
|
|
|
3 |
p. e142-e144
|
artikel
|
| 61 |
Innovation challenge contests to enhance HIV responses
|
Tucker, Joseph D
|
|
2018
|
|
3 |
p. e113-e115
|
artikel
|
| 62 |
Intertwined epidemics: progress, gaps, and opportunities to address intimate partner violence and HIV among key populations of women
|
El-Bassel, Nabila
|
|
|
|
3 |
p. e202-e213
|
artikel
|
| 63 |
Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis
|
Mills, Edward J
|
|
2014
|
|
3 |
p. e104-e111
nvt p.
|
artikel
|
| 64 |
Is HIV a provoking factor for venous thrombotic events?
|
Rasmussen, Line D
|
|
2019
|
|
3 |
p. e144-e146
|
artikel
|
| 65 |
Laws and policies against MSM and HIV control in Africa
|
Bigna, Jean Joel
|
|
|
|
3 |
p. e148-e149
|
artikel
|
| 66 |
Lenacapavir plus two bNAbs: feasible, with some caveats
|
Martinez, Esteban
|
|
|
|
3 |
p. e132-e133
|
artikel
|
| 67 |
Let's treat everyone with HIV now: what happens next?
|
Cohen, Myron S
|
|
2016
|
|
3 |
p. e109-e110
nvt p.
|
artikel
|
| 68 |
Life in the time of antiretrovirals in South Africa
|
Furin, Jennifer
|
|
2017
|
|
3 |
p. e95-e96
nvt p.
|
artikel
|
| 69 |
Living authentically despite prejudice and marginalisation
|
Burki, Talha
|
|
|
|
3 |
p. e145
|
artikel
|
| 70 |
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
|
Trickey, Adam
|
|
|
|
3 |
p. e176-e185
|
artikel
|
| 71 |
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study
|
Verheij, Eveline
|
|
|
|
3 |
p. e164-e174
|
artikel
|
| 72 |
Metrics and benchmarks for HIV transition
|
Ghys, Peter D
|
|
2019
|
|
3 |
p. e150
|
artikel
|
| 73 |
Metrics and benchmarks for HIV transition – Authors' reply
|
Pandey, Abhishek
|
|
2019
|
|
3 |
p. e150
|
artikel
|
| 74 |
More evidence for dolutegravir as first-line ART for all
|
Estill, Janne
|
|
|
|
3 |
p. e154-e155
|
artikel
|
| 75 |
Moving on from the failed HIV vaccine clinical trial
|
Adepoju, Paul
|
|
|
|
3 |
p. e161
|
artikel
|
| 76 |
National sex work policy and HIV prevalence among sex workers: an ecological regression analysis of 27 European countries
|
Reeves, Aaron
|
|
2017
|
|
3 |
p. e134-e140
nvt p.
|
artikel
|
| 77 |
Need for clear inclusion criteria in reviews of antiretroviral treatments
|
Calmy, Alexandra
|
|
|
|
3 |
p. e150
|
artikel
|
| 78 |
Need for clear inclusion criteria in reviews of antiretroviral treatments – Authors' reply
|
Gibas, Kevin M
|
|
|
|
3 |
p. e150-e151
|
artikel
|
| 79 |
Network meta-analyses: powerful but not without perils
|
Geng, Elvin H
|
|
2014
|
|
3 |
p. e95-e96
nvt p.
|
artikel
|
| 80 |
Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis
|
Ford, Nathan
|
|
|
|
3 |
p. e150-e159
|
artikel
|
| 81 |
Overcoming resistance to HIV testing in sub-Saharan Africa
|
Sweat, Michael
|
|
2016
|
|
3 |
p. e106-e107
nvt p.
|
artikel
|
| 82 |
Panobinostat clinical trial highlights the challenges towards an HIV cure
|
Palmer, Clovis S
|
|
2014
|
|
3 |
p. e103-
1 p.
|
artikel
|
| 83 |
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
|
Ruel, Theodore D
|
|
|
|
3 |
p. e149-e157
|
artikel
|
| 84 |
Philippine epidemic calls for urgent action on HIV
|
The Lancet HIV,
|
|
2016
|
|
3 |
p. e105-
1 p.
|
artikel
|
| 85 |
Point-of-care assays for early infant diagnosis in Zimbabwe
|
Girdwood, Sarah J
|
|
2019
|
|
3 |
p. e146-e147
|
artikel
|
| 86 |
Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis
|
Jain, Vivek
|
|
2017
|
|
3 |
p. e122-e133
nvt p.
|
artikel
|
| 87 |
Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial
|
Moodley, Dhayendre
|
|
|
|
3 |
p. e154-e163
|
artikel
|
| 88 |
PrEP in China: choices are ahead
|
Xu, Junjie
|
|
|
|
3 |
p. e155-e157
|
artikel
|
| 89 |
¡PrEP Ya! Latin America wants PrEP, and Brazil leads the way
|
Galea, Jerome T
|
|
2018
|
|
3 |
p. e110-e112
|
artikel
|
| 90 |
Prevention of HIV transmission by antiretroviral therapy
|
Lundgren, Jens
|
|
2018
|
|
3 |
p. e108-e109
|
artikel
|
| 91 |
Primary HIV-1 infection in users of pre-exposure prophylaxis
|
Ambrosioni, Juan
|
|
|
|
3 |
p. e166-e174
|
artikel
|
| 92 |
Prioritising pleasure and correcting misinformation in the era of U=U
|
Calabrese, Sarah K
|
|
|
|
3 |
p. e175-e180
|
artikel
|
| 93 |
Progress in HIV care outcomes among Black men in San Francisco
|
Scheer, Susan
|
|
|
|
3 |
p. e126
|
artikel
|
| 94 |
Putting participants at the centre of HIV cure research
|
Dubé, Karine
|
|
2019
|
|
3 |
p. e147-e149
|
artikel
|
| 95 |
Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda
|
Ratmann, Oliver
|
|
|
|
3 |
p. e173-e183
|
artikel
|
| 96 |
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensus
|
Croxford, Sara E
|
|
|
|
3 |
p. e195-e201
|
artikel
|
| 97 |
Reducing transmission of HIV in southeastern USA
|
Franco-Paredes, Carlos
|
|
2017
|
|
3 |
p. e101-e102
nvt p.
|
artikel
|
| 98 |
Resistance to first-line ART and a role for dolutegravir
|
Kaplan, Richard
|
|
2018
|
|
3 |
p. e112-e113
|
artikel
|
| 99 |
Response to Thailand's commitment to support community-led HIV services
|
Phanuphak, Nittaya
|
|
|
|
3 |
p. e141-e142
|
artikel
|
| 100 |
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
|
Grinsztejn, Beatriz
|
|
2018
|
|
3 |
p. e136-e145
|
artikel
|
| 101 |
Rethinking the challenges of paediatric HIV diagnosis
|
Sohn, Annette H
|
|
|
|
3 |
p. e123-e124
|
artikel
|
| 102 |
Retiring the term AIDS for more descriptive language
|
Núñez, Isaac
|
|
|
|
3 |
p. e195-e198
|
artikel
|
| 103 |
Russia passes anti-LGBT+ law
|
Holt, Ed
|
|
|
|
3 |
p. e152
|
artikel
|
| 104 |
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
|
Eron, Joseph J
|
|
|
|
3 |
p. e146-e155
|
artikel
|
| 105 |
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
|
Schürmann, Dirk
|
|
|
|
3 |
p. e164-e172
|
artikel
|
| 106 |
Severe bacterial infections: overlooked opportunistic diseases
|
Anglaret, Xavier
|
|
2017
|
|
3 |
p. e94-e95
nvt p.
|
artikel
|
| 107 |
Shared goals for tuberculosis and HIV
|
The Lancet HIV,
|
|
2018
|
|
3 |
p. e107
|
artikel
|
| 108 |
Smoking and HIV: confronting the epidemic
|
Diaz, Philip
|
|
2018
|
|
3 |
p. e109-e110
|
artikel
|
| 109 |
Stigma reduction is key to improving the HIV care continuum
|
Poteat, Tonia C
|
|
|
|
3 |
p. e144-e145
|
artikel
|
| 110 |
Strategies for engaging men in HIV services
|
Colvin, Christopher J
|
|
2019
|
|
3 |
p. e191-e200
|
artikel
|
| 111 |
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
|
Moyle, Graeme
|
|
|
|
3 |
p. e156-e166
|
artikel
|
| 112 |
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study
|
Pantazis, Nikos
|
|
2014
|
|
3 |
p. e119-e126
nvt p.
|
artikel
|
| 113 |
Thailand's commitment to support community-led HIV services
|
Lertpiriyasuwat, Cheewanan
|
|
|
|
3 |
p. e141
|
artikel
|
| 114 |
The changing virulence of HIV
|
Herbeck, Joshua
|
|
2014
|
|
3 |
p. e99-e100
nvt p.
|
artikel
|
| 115 |
The effect of incentives on HIV research must be studied
|
Brown, Brandon
|
|
2019
|
|
3 |
p. e142-e143
|
artikel
|
| 116 |
The end of AIDS?
|
The Lancet HIV,
|
|
2015
|
|
3 |
p. e71-
1 p.
|
artikel
|
| 117 |
The first step on the continuum of care
|
The Lancet HIV,
|
|
2014
|
|
3 |
p. e94-
1 p.
|
artikel
|
| 118 |
The HIV care continuum in black MSM in the USA
|
Poteat, Tonia
|
|
2014
|
|
3 |
p. e97-e98
nvt p.
|
artikel
|
| 119 |
The holy grail of HIV programme effectiveness
|
Solomon, Sunil Suhas
|
|
2017
|
|
3 |
p. e96-e98
nvt p.
|
artikel
|
| 120 |
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
|
Dorward, Jienchi
|
|
|
|
3 |
p. e158-e165
|
artikel
|
| 121 |
The legacy of a lost generation
|
Burki, Talha
|
|
2019
|
|
3 |
p. e154
|
artikel
|
| 122 |
The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study
|
Estill, Janne
|
|
2016
|
|
3 |
p. e132-e139
nvt p.
|
artikel
|
| 123 |
The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study
|
Gooden, Tiffany E
|
|
|
|
3 |
p. e172-e181
|
artikel
|
| 124 |
The role of HIV biology in defining virological failure
|
Boyce, Ceejay L
|
|
|
|
3 |
p. e133-e134
|
artikel
|
| 125 |
The tuberculosis emergency in eastern Europe
|
Furin, Jennifer
|
|
2016
|
|
3 |
p. e107-e108
nvt p.
|
artikel
|
| 126 |
The USA can end its HIV epidemic if it gets the politics right
|
The Lancet HIV,
|
|
2019
|
|
3 |
p. e141
|
artikel
|
| 127 |
Time, population mobility, and HIV transmission
|
Cassels, Susan
|
|
|
|
3 |
p. e151-e152
|
artikel
|
| 128 |
Time to PrEP for zero HIV transmissions in the UK?
|
The Lancet HIV,
|
|
|
|
3 |
p. e149
|
artikel
|
| 129 |
Time to tackle late diagnosis
|
The Lancet HIV,
|
|
|
|
3 |
p. e139
|
artikel
|
| 130 |
Tough requirements for new antiretroviral drugs
|
de Mendoza, Carmen
|
|
|
|
3 |
p. e150-e151
|
artikel
|
| 131 |
Towards a new health diplomacy in eastern Ukraine
|
Kazatchkine, Michel
|
|
2017
|
|
3 |
p. e99-e101
nvt p.
|
artikel
|
| 132 |
Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort study
|
Patel, Kunjal
|
|
|
|
3 |
p. e184-e192
|
artikel
|
| 133 |
Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study
|
Reniers, Georges
|
|
2017
|
|
3 |
p. e113-e121
nvt p.
|
artikel
|
| 134 |
Trying to cure HIV with immunotherapy: not so simple
|
Kent, Stephen J
|
|
2015
|
|
3 |
p. e72-e73
nvt p.
|
artikel
|
| 135 |
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study
|
Podlekareva, Daria N
|
|
2016
|
|
3 |
p. e120-e131
nvt p.
|
artikel
|
| 136 |
Understanding HIV risk and vulnerability among cisgender men with transgender partners
|
Poteat, Tonia
|
|
|
|
3 |
p. e201-e208
|
artikel
|
| 137 |
Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modelling study
|
Rosenberg, Eli S
|
|
2014
|
|
3 |
p. e112-e118
nvt p.
|
artikel
|
| 138 |
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
|
Iwuji, Collins C
|
|
2018
|
|
3 |
p. e116-e125
|
artikel
|
| 139 |
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
|
Phillips, Andrew N
|
|
|
|
3 |
p. e193-e200
|
artikel
|
| 140 |
We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy
|
Kantor, Rami
|
|
|
|
3 |
p. e202-e208
|
artikel
|
| 141 |
What future for HIV vaccines?
|
The Lancet HIV,
|
|
|
|
3 |
p. e143
|
artikel
|
| 142 |
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap
|
Joseph Davey, Dvora L
|
|
|
|
3 |
p. e214-e222
|
artikel
|
| 143 |
Where have all the patients gone?
|
Padian, Nancy S
|
|
2015
|
|
3 |
p. e78-e79
nvt p.
|
artikel
|
| 144 |
Women lead the way in the HIV response
|
The Lancet HIV,
|
|
|
|
3 |
p. e131
|
artikel
|
Tijdschrift beschrijving